Teva’s Atorvastatin Calcium Tablets are the generic equivalent forms of Pfizer’s Lipitor.
During Ranbaxy’s 180-day first-to-file exclusivity period, a portion of the profits from its sales of Atorvastatin Calcium Tablets will be paid to Teva asd it has launched the product.
The drug is proven that along with diet and exercise it lowers bad cholesterol and along with diet reduces the risk of heart attack and stroke in patients with heart disease or several common risk factors for heart disease.